Close

Explore AI

Explore GPTs

Explore AI News

Explore AI Videos

Explore AI for Jobs

Latest Illumina AI Videos

Find the latest for Illumina company videos

Follow
... 6:2
Celestial's AI Efficiency Tech

Bloomberg Technology

1+ months ago 1K views

The Photonic Fabric technology accelerates AI computing by interconnecting processors with light, reducing energy consumption and improving bandwidth and latency. With AI workloads growing exponentially, this technology is crucial for scaling and integrating into the next generation of AI accelerators. Multiple partnerships with hyperscale data center companies are underway to ensure the required volume manufacturing for the technology. The strategic investment from firms like Fidelity and BlackRock indicates strong market confidence, positioning the company for significant growth in the AI sector, especially as applications in sectors like automotive emerge.
03:11 - 03:44

Switching from copper to photonic solutions for lower energy and higher bandwidth.

Celestial AI AI hardware AI Startups
... 9:26
The Role of AI in Personalized Medicine Tailoring Treatments for Every Patient

The Transforming Treatment Institute

1+ months ago 3K views

Personalized medicine, driven by advanced AI technologies, transforms healthcare by tailoring treatments to individual genetic profiles and environmental factors. This approach moves beyond one-size-fits-all practices, enabling predictive analytics for conditions such as heart disease and cancer. AI's power in genomics allows for faster and cheaper sequencing of DNA, assisting in early diagnosis and customized treatment plans. Future advancements promise a shift from reactive to proactive healthcare, empowering patients and doctors alike through continuous data monitoring and tailored interventions, ultimately enhancing survival rates and improving overall health outcomes.
02:38 - 02:42

Genomic profiling with AI identifies mutations for targeted cancer therapies.

Machine Learning Healthcare
... 13:50
IDOLpro: Generative AI for Chemistry | Tech talk with Amit Kadan

SandboxAQ

1+ months ago 2K views

IDOLpro combines AI and physics to enhance drug design by generating small molecules tailored for specific protein targets. Traditional methods are time-consuming, as they require evaluating vast chemical libraries. In contrast, IDOLpro uses generative AI to jump directly to relevant chemical spaces, optimizing for properties like synthetic accessibility and binding affinity. The framework employs a diffusion model guided by machine learning and physics-based scoring functions, significantly improving the efficiency of drug discovery. Initial evaluations show IDOLpro outperformed existing methods in generating viable drug candidates with desirable properties.
04:00 - 04:04

Iterative grading in IDOLpro enhances molecular properties like binding affinity.

SandboxAQ Machine Learning Research & Innovations
... 8:29
IPA Stock - AI Company to Watch (Update)

Blaze Capital

1+ months ago 10K views

Immuno Precise Antibodies (IPA), listed on NASDAQ as IPA, aims to revolutionize healthcare and drug discovery through its patented Lens AI technology. With over 90% of clinical drug developments failing, IPA addresses this challenge by accelerating drug discovery and integrating artificial intelligence with biological data. Their HFT patterns program introduces unique signature sequences, enabling the harmonization of complex biological data. The potential market for AI in drug discovery is projected to be worth $24.6 billion by 2029. The company is making strides in developing precision-targeted treatments, particularly for cancer, enhancing drug efficacy with fewer side effects.
04:01 - 04:06

In silico antibodies targeting tumor proteins show AI's efficacy in drug development.

Immunoprecise Antibodies Ltd Finance
... 34:12
Tempus A.I. Stock (TEM) is Crazy! | Deep Analysis on TEM Stock

H Invests

1+ months ago 2K views

Tempus AI focuses on leveraging artificial intelligence to enhance healthcare diagnostics, particularly in oncology. Founded in 2015, it has been using AI and machine learning to analyze laboratory test results in context with patient histories. The CEO discusses how the company aims to improve patient outcomes through personalized treatment plans by utilizing extensive genomic data while also expanding its services to cover various diseases beyond cancer. Despite operating at a loss, Tempus AI is experiencing rapid growth and plans to achieve profitability by 2025, driving significant potential in the healthcare market.
11:24 - 12:02

Tempus AI has a unique position with a database 20 times larger for cancer genomics.

Tempus Machine Learning Finance
... 10:30
Tempus AI & Palantir Stock Are SHOCKING The Market!

Data Dispatch

1+ months ago 6K views

Tempest AI's stock surged to $72 from $40 after acquiring Ambry Genetics for $600 million, boosting market confidence. Analysts are raising price targets, now averaging $63.12, with a high of $74. Meanwhile, Palantir remains steady above $100 amid discussions on valuation and potential government contracts, emphasizing its role in defense. The broader market exhibits resilience, with significant gains noted despite minor tariff uncertainties and mixed earnings reports from major players. Commentary on AI's critical role in these developments highlights the ongoing transformation within the industry and investor sentiment.
06:54 - 07:05

Palantir emphasizes AI in defense, boosting its market position.

Tempus AI Finance
... 8:55
Brian Keane CEO Diagen AI | Global Blockchain Show 2024!

pinoyweb3TV

1+ months ago 1K views

Diane AI specializes in AI-driven protein design for drug discovery, focusing on delivering innovative solutions in healthcare. The company highlights successful collaborations, notably with the University of North Carolina, to develop new therapeutic molecules, particularly for cancer treatment. The emphasis is on optimizing vaccine delivery and diagnostics while addressing the potential impact of AI on job dynamics within the pharmaceutical industry. Future growth involves partnerships across regions, like in the Mina region, and continuous investment in evolving AI technologies to enhance drug discovery processes and public health outcomes.
04:44 - 05:08

Diane AI believes socio-economic factors will drive job creation in the pharmaceutical sector.

Diagen AI Blockchain AI Startups
... 24:21
AI Discovered a Hidden Message in the DNA of All Living Things

FactFile

1+ months ago 3K views

AI is unraveling hidden secrets in DNA, revealing that non-coding DNA holds critical functions beyond mere genetic blueprinting. Advanced AI tools like Grover and Luca have enabled the discovery of over 16,000 new RNA viruses and ancient civilizations' geoglyphs. Furthermore, groundbreaking developments in translating ancient languages using AI and discovering new antibiotics offer insights into personalized medicine and antibiotic resistance. These breakthroughs illustrate the dual potential of AI in both uncovering historical mysteries and addressing modern challenges in medicine.
04:33 - 04:53

AI uncovers 303 new geoglyphs in Peru’s Nasca Lines, enriching archaeological insight.

Machine Learning Research & Innovations
... 24:21
AI Discovered a Hidden Message in the DNA of All Living Things

FactFile

1+ months ago 3K views

AI is unraveling hidden secrets in DNA, revealing that non-coding DNA holds critical functions beyond mere genetic blueprinting. Advanced AI tools like Grover and Luca have enabled the discovery of over 16,000 new RNA viruses and ancient civilizations' geoglyphs. Furthermore, groundbreaking developments in translating ancient languages using AI and discovering new antibiotics offer insights into personalized medicine and antibiotic resistance. These breakthroughs illustrate the dual potential of AI in both uncovering historical mysteries and addressing modern challenges in medicine.
04:33 - 04:53

AI uncovers 303 new geoglyphs in Peru’s Nasca Lines, enriching archaeological insight.

Machine Learning Research & Innovations